Survey: Confusion over key requirements means clinical trials aren’t registered; Many doctors are in the dark about how FDA approves devices and drugs

Taking stock of the drug industry, from the lab to the medicine chest

January 16, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Survey: Confusion over key requirements means clinical trials aren't registered and results aren't reported Between 25% and 30% of responsible parties are unconcerned with potential consequences for failing to comply with disclosure requirements. By Ed Silverman STAT+ | Many doctors are in the dark about how FDA approves devices and drugs, survey finds Doctors prescribe medical devices, but a new survey finds that many don't know how the FDA approval process works. By Lizzy Lawrence STAT+ | The new NIH director is walking a tightrope on Biden's drug pricing vision NIH Director Monica Bertagnolli is at the center of the drug pricing debate over so-called "march-in rights." She's taking a cautious line. By Sarah Owermohle Adobe The WHO and drug regulators want to reformulate the flu vaccine. It's easier said than done Vaccine manufacturers have been urged to drop the component known as B/Yamagata from flu vaccines as quickly as possible. By Helen Branswell

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser